Qian Wang

Treatment outcomes and prognosis of immune checkpoint inhibitors therapy in patients with advanced thymic carcinoma: A multicentre retrospective study.

Yi Hao, Yongchang Zhang, Z. Song, 2022, European journal of cancer.

KN026 (anti-HER2 bispecific antibody) in patients with previously treated, advanced HER2-expressing gastric or gastroesophageal junction cancer.

N. Xu, Yanqiao Zhang, J. Ying, 2022, European journal of cancer.

618MO Local therapy to the primary tumour for newly diagnosed, oligo-metastatic prostate cancer: A prospective randomized, phase II, open-label trial

B. Dai, D. Ye, G. Lin, 2020 .

The prognostic impact of mild and severe immune-related adverse events in non-small cell lung cancer treated with immune checkpoint inhibitors: a multicenter retrospective study

Yiping Zhang, Z. Song, Wenxian Wang, 2021, Cancer Immunology, Immunotherapy.

A phase II study evaluating KN026 monotherapy in patients (pts) with previously treated, advanced HER2-expressing gastric or gastroesophageal junction cancers (GC/GEJC).

Yanqiao Zhang, J. Ying, N. Xu, 2022, Journal of Clinical Oncology.

Response and acquired resistance to MET inhibitors in de novo MET fusion-positive advanced non-small cell lung cancer.

Jin-Ji Yang, W. Feng, W. Zhong, 2023, Lung cancer.